 OBGYN.net Online E-Detailing Survey |
 |
|
 |
|
|
|||
|
||||
|
||||
Click here to take this survey!
As of 23-Nov-09 01:48 PM there are 152 Online E-detailing Survey Respondents
from the Asia (click here for all surveys)
I am best described as a: (66.45%) 101 Ob/Gyn physician (9.87%) 15 Resident or Medical Student (7.24%) 11 Family Practice or General Practice (5.26%) 8 Other MD Specialty (4.61%) 7 Reproductive Endocrinologist (3.95%) 6 Other Medical Professional (2.63%) 4 Maternal Fetal Medicine click here to see results for MD only surveys (excluding other medical professionals) click here to see listing of other MD specialties...
(these questions were added at a later point in the survey which explains the smaller sample size)
Sex: (57.41%) 62 Male (42.59%) 46 Female
Age: (43.52%) 47 30-39 (36.11%) 39 40-49 (12.96%) 14 under 30 (4.63%) 5 50-59 (2.78%) 3 60 and over
Region: (100.00%) 152 Asia
Country: (34.21%) 52 India (11.18%) 17 Indonesia (7.89%) 12 Philippines (7.24%) 11 Malaysia (7.24%) 11 Pakistan (5.92%) 9 Thailand (4.61%) 7 Korea, Republic of (4.61%) 7 Taiwan, Province of China (3.95%) 6 Russian Federation (3.29%) 5 China (2.63%) 4 Japan (2.63%) 4 Singapore (1.97%) 3 Sri Lanka (0.66%) 1 Bangladesh (0.66%) 1 Hong Kong (0.66%) 1 Nepal (0.66%) 1 Vietnam
Have you ever taken an online pharmaceutical detail? (39.47%) 60 interested (38.82%) 59 no (19.08%) 29 yes (2.63%) 4 not_interested click here to see listing from which company or website...
In your busy schedule do you find yourself spending more or less time than you did in the past talking with face to face pharmaceutical sales representatives in your office monthly? (36.84%) 56 less (30.92%) 47 About the Same (26.97%) 41 more (5.26%) 8 I do not see pharmaceutical representatives
How would you most prefer to get drug and product information? (43.42%) 66 On the Internet with the option to request a face-to-face visit or samples (25.00%) 38 By face-to-face visit only (15.79%) 24 On the Internet only (9.87%) 15 On the Internet with the option to go into a real-time chat with a representative (5.92%) 9 On the Internet with a phone-in number
What would you find to be the best enticement or reward to take an online drug detail? (51.97%) 79 Free access to full text Cochrane database (26.97%) 41 I do not need any enticement but would take it if I am interested in the product (17.11%) 26 Coupon towards a free medical book or merchandise valued at up to $15 USD (3.95%) 6 I would not take an online drug detail even with enticement
What features do you think are most important in an online drug detail? (check all that apply) (86.84%) 132 Ability to find out about new treatment options (73.68%) 112 Ability to get the information at my convenience (60.53%) 92 Ability to get feedback and questions answered by the manufacturer of the product (53.95%) 82 Ability to get supporting opinion leader advice and opinions about the product (35.53%) 54 Ability to request a face-to-face sales rep visit click here to see listing of other requested features...
Do you want to get more product information delivered to you via the Internet in the future? (64.47%) 98 Yes, I think this is the trend of the future (29.61%) 45 Yes, but the online detail should support, not replace the face-to-face meetings (5.92%) 9 No, I would rather just have the sales force drop by my office
What do you believe is the most effective way for pharmaceutical companies to let you know about the opportunity to take an online detail? (42.76%) 65 By promoting it and making it available on OBGYN.net and in the OBGYN.net email newsletter (30.26%) 46 By an email notification sent to me direct from the company (12.50%) 19 Being told about it by my face to face pharmaceutical representative visiting in my office (11.18%) 17 By direct print mail sent to my office (3.29%) 5 By advertising in medical magazines
Would you be interested in receiving online details on OBGYN.net in the future? (96.71%) 147 Yes (3.29%) 5 No
Would you like to be notified by email with the names of the winners and the results of this survey? (92.76%) 141 Yes (7.24%) 11 No